Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.

The COVID-19 International Modelling Consortium (CoMo Consortium) - image of he world highlighting countries with CoMo members, its logo and the text CoMo Consortium

The CoMo Consortium is delighted to have been awarded funding by the University’s COVID-19 Research Response Fund, enabling the group to continue to support country members, predominantly low- and middle-income countries, who require modelling support for non-pharmaceutical interventions such as social distancing, mask wearing and handwashing, while they wait for vaccines and to support these countries with modelling the implementation of vaccine programmes.

CoMo uses an innovative participatory approach, leveraging experts from the University of Oxford and other collaborating partners to provide capacity building and support to in-country modellers.

Lisa J. White, Professor of Modelling and Epidemiology at the University of Oxford and Director of the CoMo Consortium, explains:

 “Our approach in the CoMo Consortium represents a new more equitable way to conduct pandemic modelling. Here, experts within the country teams take the leading role in modelling the pandemic working closely with national policymakers. Researchers at Oxford provide technical and consultative support as needed. Modelling work is carried out within the health and policy context of each country leading to rapid uptake of results via continuous communication with the decisionmakers.”

This approach has enabled in-country teams to assist policymakers in making evidence-based decisions to contain the spread of COVID-19, supported by epidemiological and economic models adapted to each country’s context. In addition to this the group has published a series of papers which are now published.

For more information, visit our BMJ co-hosted website

Similar stories

Global Research on AntiMicrobial resistance (GRAM) project

Antimicrobial resistance (AMR) is responsible for at least 1.27 million deaths per year — with over 97,000 deaths in 2019 in SE Asia alone, according to a study published in The Lancet by the Global Research on AntiMicrobial resistance (GRAM) project, who urged urgent action from policymakers and health communities to avoid further preventable deaths.

Susie, Phaik Yeong, Richard and Paul among new full Oxford professors!

In the 2021 Oxford Recognition of Distinction round, four MORU colleagues were awarded Full Professor title.

RECOVERY Trial launches in South Africa

The world’s largest clinical trial investigating treatments for COVID-19 has now launched in South Africa, with the first patient recruited today. This is the fifth country to take part in RECOVERY, joining Nepal, Indonesia, Vietnam, and the United Kingdom.

RECOVERY Trial wins ‘Oscar of Higher Education’ for STEM Research Project of the year

The RECOVERY Trial has been awarded the 2021 Times Higher Education (THE) Award in the ‘Research Project of the Year: STEM’ category.

Antibiotic accountability: how countries and companies perform

Patients in north Africa and the Middle East are using antibiotics in sharply rising quantities far beyond the global average, raising concerns over the escalating risks of resistance to medicines to treat bacterial infections. Estimated antibiotic consumption for 204 countries between 2000 and 2018 shows a 46 per cent increase in global antibiotic usage, with a surge in nations including India and Vietnam.

Paul Newton named ASTMH Distinguished International Fellow

Professor Paul Newton was announced new Distinguished International Fellow at the ASTMH Annual Meeting Awards Ceremony on the 17th November. This distinction formally recognizes individuals who have made eminent contributions to a particular aspect of tropical medicine or hygiene.